Multi-center phase 3 trial of chlorhexidine gluconate chip for the use in subjects with peri-implantitis

Trial Profile

Multi-center phase 3 trial of chlorhexidine gluconate chip for the use in subjects with peri-implantitis

Recruiting
Phase of Trial: Phase III

Latest Information Update: 02 Jun 2017

At a glance

  • Drugs Chlorhexidine (Primary)
  • Indications Peri-implantitis
  • Focus Registrational; Therapeutic Use
  • Sponsors Dexcel-Pharma
  • Most Recent Events

    • 25 May 2017 Planned End Date changed from 1 Jul 2017 to 1 Jun 2018.
    • 25 May 2017 Planned primary completion date changed from 1 May 2017 to 1 Dec 2017.
    • 17 Feb 2015 Planned End Date changed from 1 Apr 2016 to 1 Aug 2016 as reported by ClinicalTrials.gov record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top